287 related articles for article (PubMed ID: 27206658)
1. Differential Lyn-dependence of the SHIP1-deficient mast cell phenotype.
Nunes de Miranda SM; Wilhelm T; Huber M; Zorn CN
Cell Commun Signal; 2016 May; 14(1):12. PubMed ID: 27206658
[TBL] [Abstract][Full Text] [Related]
2. Stimulus strength determines the BTK-dependence of the SHIP1-deficient phenotype in IgE/antigen-triggered mast cells.
Zorn CN; Simonowski A; Huber M
Sci Rep; 2018 Oct; 8(1):15467. PubMed ID: 30341350
[TBL] [Abstract][Full Text] [Related]
3. IgG-Independent Co-aggregation of FcεRI and FcγRIIB Results in LYN- and SHIP1-Dependent Tyrosine Phosphorylation of FcγRIIB in Murine Bone Marrow-Derived Mast Cells.
Gast M; Preisinger C; Nimmerjahn F; Huber M
Front Immunol; 2018; 9():1937. PubMed ID: 30210494
[TBL] [Abstract][Full Text] [Related]
4. Dysregulated FcepsilonRI signaling and altered Fyn and SHIP activities in Lyn-deficient mast cells.
Hernandez-Hansen V; Smith AJ; Surviladze Z; Chigaev A; Mazel T; Kalesnikoff J; Lowell CA; Krystal G; Sklar LA; Wilson BS; Oliver JM
J Immunol; 2004 Jul; 173(1):100-12. PubMed ID: 15210764
[TBL] [Abstract][Full Text] [Related]
5. Positive and Negative Regulatory Roles of C-Terminal Src Kinase (CSK) in FcεRI-Mediated Mast Cell Activation, Independent of the Transmembrane Adaptor PAG/CSK-Binding Protein.
Potuckova L; Draberova L; Halova I; Paulenda T; Draber P
Front Immunol; 2018; 9():1771. PubMed ID: 30116247
[TBL] [Abstract][Full Text] [Related]
6. Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway.
Lessmann E; Grochowy G; Weingarten L; Giesemann T; Aktories K; Leitges M; Krystal G; Huber M
Exp Hematol; 2006 Nov; 34(11):1532-41. PubMed ID: 17046573
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of genes linked to FcepsilonRI Signaling and to cytokine and chemokine production in Lyn-deficient mast cells.
Hernandez-Hansen V; Bard JD; Tarleton CA; Wilder JA; Lowell CA; Wilson BS; Oliver JM
J Immunol; 2005 Dec; 175(12):7880-8. PubMed ID: 16339523
[TBL] [Abstract][Full Text] [Related]
8. Redundant and opposing functions of two tyrosine kinases, Btk and Lyn, in mast cell activation.
Kawakami Y; Kitaura J; Satterthwaite AB; Kato RM; Asai K; Hartman SE; Maeda-Yamamoto M; Lowell CA; Rawlings DJ; Witte ON; Kawakami T
J Immunol; 2000 Aug; 165(3):1210-9. PubMed ID: 10903718
[TBL] [Abstract][Full Text] [Related]
9. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.
Xiao W; Nishimoto H; Hong H; Kitaura J; Nunomura S; Maeda-Yamamoto M; Kawakami Y; Lowell CA; Ra C; Kawakami T
J Immunol; 2005 Nov; 175(10):6885-92. PubMed ID: 16272347
[TBL] [Abstract][Full Text] [Related]
10. Lyn kinase controls TLR4-dependent IKK and MAPK activation modulating the activity of TRAF-6/TAK-1 protein complex in mast cells.
Avila M; Martinez-Juarez A; Ibarra-Sanchez A; Gonzalez-Espinosa C
Innate Immun; 2012 Aug; 18(4):648-60. PubMed ID: 22302035
[TBL] [Abstract][Full Text] [Related]
11. Differential use of BTK and PLC in FcεRI- and KIT-mediated mast cell activation: A marginal role of BTK upon KIT activation.
Simonowski A; Wilhelm T; Habib P; Zorn CN; Huber M
Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118622. PubMed ID: 31837347
[TBL] [Abstract][Full Text] [Related]
12. Btk plays a crucial role in the amplification of Fc epsilonRI-mediated mast cell activation by kit.
Iwaki S; Tkaczyk C; Satterthwaite AB; Halcomb K; Beaven MA; Metcalfe DD; Gilfillan AM
J Biol Chem; 2005 Dec; 280(48):40261-70. PubMed ID: 16176929
[TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase epsilon is a negative regulator of FcepsilonRI-mediated mast cell responses.
Akimoto M; Mishra K; Lim KT; Tani N; Hisanaga SI; Katagiri T; Elson A; Mizuno K; Yakura H
Scand J Immunol; 2009 May; 69(5):401-11. PubMed ID: 19508371
[TBL] [Abstract][Full Text] [Related]
14. Requirement for CD45 in fine-tuning mast cell responses mediated by different ligand-receptor systems.
Grochowy G; Hermiston ML; Kuhny M; Weiss A; Huber M
Cell Signal; 2009 Aug; 21(8):1277-86. PubMed ID: 19332117
[TBL] [Abstract][Full Text] [Related]
15. SHIP negatively regulates IgE + antigen-induced IL-6 production in mast cells by inhibiting NF-kappa B activity.
Kalesnikoff J; Baur N; Leitges M; Hughes MR; Damen JE; Huber M; Krystal G
J Immunol; 2002 May; 168(9):4737-46. PubMed ID: 11971024
[TBL] [Abstract][Full Text] [Related]
16. Positive and negative regulation of Fc epsilon receptor I-mediated signaling events by Lyn kinase C-terminal tyrosine phosphorylation.
Tolar P; Dráberová L; Tolarová H; Dráber P
Eur J Immunol; 2004 Apr; 34(4):1136-45. PubMed ID: 15048725
[TBL] [Abstract][Full Text] [Related]
17. WZ3146 inhibits mast cell Lyn and Fyn to reduce IgE-mediated allergic responses in vitro and in vivo.
Park YH; Kim DK; Kim HS; Lee D; Lee MB; Min KY; Jo MG; Lee JE; Kim YM; Choi WS
Toxicol Appl Pharmacol; 2019 Nov; 383():114763. PubMed ID: 31526816
[TBL] [Abstract][Full Text] [Related]
18. Activation of murine macrophages via TLR2 and TLR4 is negatively regulated by a Lyn/PI3K module and promoted by SHIP1.
Keck S; Freudenberg M; Huber M
J Immunol; 2010 May; 184(10):5809-18. PubMed ID: 20385881
[TBL] [Abstract][Full Text] [Related]
19. SH2 domain-containing phosphatase-2 protein-tyrosine phosphatase promotes Fc epsilon RI-induced activation of Fyn and Erk pathways leading to TNF alpha release from bone marrow-derived mast cells.
McPherson VA; Sharma N; Everingham S; Smith J; Zhu HH; Feng GS; Craig AW
J Immunol; 2009 Oct; 183(8):4940-7. PubMed ID: 19786542
[TBL] [Abstract][Full Text] [Related]
20. PTPalpha activates Lyn and Fyn and suppresses Hck to negatively regulate FcepsilonRI-dependent mast cell activation and allergic responses.
Samayawardhena LA; Pallen CJ
J Immunol; 2010 Nov; 185(10):5993-6002. PubMed ID: 20944008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
